Applied Clinical Trials
April 01, 2012
Issue PDF
21
4
INFORMATION TECHNOLOGY : Enhancing Risk Assessment and Mitigation REGULATORY : Sunshine Act?s Impact on the Industry Implementation of Objective Internal Monitoring Also in this issue : Impact of Transparency Policies, EMA?s Executive Director Faces Multiple Challenges, The Roles of Healthcare and Research, HIV Vaccine Trials
April 01, 2012
Business News
21
4
Industry news focusing on the people and organizations who work in the clinical trials profession.
April 01, 2012
View from Washington
21
4
Demand for more information on study results and investigator payments create challenges.
April 01, 2012
CTI Insights
21
4
Healthcare and research should pass useful information back and forth whenever possible.
April 01, 2012
News
21
4
PHACT is making inroads in drug development for neglected disease.
April 01, 2012
Global News
21
4
The EFGCP has organized a meeting next month in Trondheim, Norway, that will focus specifically on complex cases.
April 01, 2012
Feature Article
21
4
The amendment addresses data concerns for both physicians and drug/device manufacturers.
April 01, 2012
View from Brussels
21
4
The new Executive Director of the EMA has managed to stay calm under financial and political pressure.
April 01, 2012
News
21
4
ERT and UCLA partner in postmarket studies with an eye toward telehealth.
April 01, 2012
News
21
4
A new service is launching at the end of the month that should help make recruitment easier.
April 01, 2012
Feature Article
21
4
A quantitative approach to enhancing risk assessment and mitigation in drug development.
April 01, 2012
News
21
4
Allison Burmeister discussed the average cost increase based on the per patient cost in a clinical trial during her presentation at the ExL Pharma C.R.O.W.N. Event.
April 01, 2012
21
4
There's a rapidly growing trend towards targeted (or risk-based) site monitoring and data review. However, some organizations remain concerned about the potential impact on data quality.
April 01, 2012
Feature Article
21
4
Sponsors are responsible for monitoring studies, patient safety, and data integrity.
April 01, 2012
A Closing Thought
21
4
Researchers who work on HIV vaccines face a major challenge: convincing members of at-risk communities to volunteer for these trials.
April 01, 2012
News
21
4
The benefits to virtual trials seem endless.